Cargando…
The Impact of Advanced Age on Major Cardiovascular Events and Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing a Pharmaco-Invasive Strategy
BACKGROUND: There is little research in the efficacy and safety of a pharmaco-invasive strategy (PIS) in patients ≥75 years versus <75 years of age. We aimed to evaluate and compare the influence of advanced age on the risk of death and major adverse cardiac events (MACE) in patients undergoing P...
Autores principales: | Helber, Izo, Alves, Claudia Maria Rodrigues, Grespan, Stela Maris, Veiga, Eduardo C A, Moraes, Pedro I M, Souza, José Marconi, Barbosa, Adriano H, Gonçalves Jr, Iran, Fonseca, Francisco A H, Carvalho, Antônio Carlos C, Caixeta, Adriano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247595/ https://www.ncbi.nlm.nih.gov/pubmed/32546989 http://dx.doi.org/10.2147/CIA.S218827 |
Ejemplares similares
-
Cardiogenic shock after ST elevation myocardial infarction and IABP-SHOCK II risk score validation in a cohort treated with pharmacoinvasive strategy
por: Moraes, Pedro Ivo M, et al.
Publicado: (2019) -
Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing pharmacoinvasive treatment
por: de Andrade Falcão, Felipe José, et al.
Publicado: (2013) -
Metrics of care and cardiovascular outcomes in patients with ST-elevation myocardial infarction treated with pharmacoinvasive strategy: a decade-long network in a populous city in Brazil
por: De Marqui Moraes, Pedro Ivo, et al.
Publicado: (2023) -
Pharmaco‐Invasive Strategy: The Answer to Improving ST‐Elevation–Myocardial Infarction Care
por: Mentias, Amgad, et al.
Publicado: (2020) -
Pharmaco-mechanic Antithrombotic Strategies to Reperfusion of the Infarct-Related Artery in Patients with ST-Elevation Acute Myocardial Infarctions
por: Kala, Petr, et al.
Publicado: (2013)